Granules India informs about press release

31 Jan 2022 Evaluate

Granules India has informed that it enclosed the press release on January 31st ,2022 titled ‘Granules Pharmaceuticals, Inc. concludes US FDA Audit with Three Minor Observations’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

612.35 6.25 (1.03%)
06-Jan-2025 09:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1843.50
Dr. Reddys Lab 1349.95
Cipla 1496.60
Lupin 2363.15
Zydus Lifesciences 967.30
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.